Explore Our Library of Biomanufacturing Resources & Technical Data

Application Notes

Cellastim S – Reconstitution Application Note

rHSA Reconstitution Video Protocol

OptiVERO – Virus Production Using VERO Cells with Microcarriers Without Serum in Chemically Defined Cell Culture Media

Using Recombinant Transferrin in the Expansion of Hematopoietic Stem Cells Application Note

Blog

Albumin in Drug Delivery: Cancer’s Unexpected Achilles’ Heel

Evolving Challenges in Closed-System Biomanufacturing

How Regulatory Bodies Are Driving the Shift to Animal-Origin-Free Solutions in Cell Therapy and Vaccine Development

Innovative Solutions in Closed-System Biomanufacturing: Exploring the Tools and Technologies Driving Sterility and Efficiency

InVitria’s Top Insights from ISCT 2018 – Montreal

Recombinant Virus Platforms are Out in Front in the Race to Develop Vaccines Against SARS-CoV-2 and COVID-19 Disease

Scaling Innovation: How DiscGenics and InVitria are Leading the Future of Cell Therapy

Why Do Some Biologics Cross the Finish Line—While Others Crash and Burn?

Catalog

InVitria Product Catalog

Data Sheets

Cellastim S – Data Sheet

Journal Articles (DOI Links)

Utilization of Recombinant Albumins in the Expansion of Human T Lymphocytes

News

InVitria Launches Optibumin 25 rHSA

Posters

Advancing Vaccine Excellence

Cellastim S – Optimizing Antibody Production in Animal-Free Media with the Supplementation of Recombinant Human Albumin

SDS

Cellastim S – Safety Data Sheet

Use Guidelines

Cellastim S – Guidelines for Use

Webinar

Accelerating Vaccine Development Through Use of Blood-Free Components

White Papers

Cellastim S – Recombinant Human Serum Albumin in the Generation of Functional Cardiomyocytes from Pluripotent Stem Cells

Emergence of Blood-Free Recombinant Human Albumin